Brief: Avalo Therapeutics Announces 1-For-240 Reverse Stock Split

Avalo Therapeutics

27/12/2023 12:19

Dec 27 (Reuters) - Avalo Therapeutics Inc  AVTX.O :
    * AVALO THERAPEUTICS ANNOUNCES 1-FOR-240 REVERSE STOCK SPLIT
    * COMPANY'S COMMON STOCK WILL TRADE ON NASDAQ CAPITAL MARKET
ON A
SPLIT-ADJUSTED BASIS BEGINNING ON DECEMBER 29, 2023

Source text for Eikon:  ID:nGNXG8P7l 
Further company coverage:  AVTX.O 

 ((Reuters.Briefs@thomsonreuters.com;))